Related Experiment Videos

Myocardial ischemia/reperfusion injury in NADPH oxidase-deficient mice

M R Hoffmeyer1, S P Jones, C R Ross

  • 1Department of Molecular and Cellular Physiology, LSU Health Sciences Center, Shreveport, LA, USA.

Circulation Research
|October 31, 2000
PubMed

Insights

NADPH oxidase deficiency did not reduce myocardial ischemia/reperfusion injury in mice. These findings suggest NADPH oxidase is not a key factor in developing heart injury and dysfunction after MI/R.

Area of Science:

  • Cardiovascular Research
  • Oxidative Stress Biology
  • Immunology

Background:

  • Oxygen-derived free radicals and neutrophils are implicated in myocardial ischemia/reperfusion (MI/R) injury.
  • NADPH oxidase is a primary source of reactive oxygen species in neutrophils.

Purpose of the Study:

  • To investigate the role of NADPH oxidase in mediating MI/R injury.
  • To determine if the absence of NADPH oxidase reduces myocardial damage and dysfunction.

Main Methods:

  • Comparison of myocardial infarct size and left ventricle function in NADPH oxidase knockout and control mice subjected to MI/R.
  • Assessment of superoxide production, leukocyte-cell interactions, and neutrophil transmigration.

Main Results:

  • Myocardial infarct size and left ventricle fractional shortening were similar between groups.
  • Superoxide production was significantly impaired in NADPH oxidase knockout mice.
  • Leukocyte rolling, adhesion, and neutrophil transmigration were unaffected by NADPH oxidase absence.

Conclusions:

  • NADPH oxidase does not appear to contribute significantly to myocardial injury or dysfunction following ischemia/reperfusion.
  • Neutrophil-mediated inflammatory responses in MI/R are not dependent on NADPH oxidase activity.

Related Concept Videos